SOUTH SAN FRANCISCO, Calif., Feb. 20, 2013 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that Daniel Swisher, Chief Executive Officer of Sunesis, will present at two upcoming investor conferences:
- RBC Capital Markets 2013 Global Healthcare Conference
Tuesday, February 26th at 8:00 AM Eastern Time
New York Palace Hotel, New York City
- Cowen & Company 33rd Annual Health Care Conference
Tuesday, March 5th at 9:20 AM Eastern Time
The Boston Marriott Copley Place, Boston
A live webcast of the presentations will be available on the Sunesis website at http://ir.sunesis.com. A replay of the webcasts will be archived on the "Calendar of Events" page in the Investors and Media section of the Sunesis website for two weeks.
About Sunesis Pharmaceuticals
Sunesis is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. Sunesis has built a highly experienced cancer drug development organization committed to advancing its lead product candidate, vosaroxin, in multiple indications to improve the lives of people with cancer. For additional information on Sunesis, please visit http://www.sunesis.com.
For additional information on Sunesis, please visit http://www.sunesis.com.
The Sunesis Pharmaceuticals, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=8773
The VALOR logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=8774
CONTACT: Investor and Media Inquiries: David Pitts Argot Partners 212-600-1902 Eric Bjerkholt Sunesis Pharmaceuticals Inc. 650-266-3717
Source:Sunesis Pharmaceuticals, Inc.